Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

JBIO Q1 2024 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

JBIOJade Biosciences, Inc.

$491M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$28,000

Operating Income

-$25M

Net Income

-$23M

EPS (Diluted)

$-29.20

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$107M

Total Liabilities

$16M

Stockholders' Equity

$91M

Cash & Equivalents

$9M

← FY 2024 All Quarters Q2 2024 →